Literature DB >> 7048654

Mosquito transmission of cultured Plasmodium falciparum.

T Ponnudurai, J P Verhave, J H Meuwissen.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 7048654     DOI： 10.1016/0035-9203(82)90298-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  6 in total

1.  Consistent safety and infectivity in sporozoite challenge model of Plasmodium vivax in malaria-naive human volunteers.

Authors:  Sócrates Herrera; Yezid Solarte; Alejandro Jordán-Villegas; Juan Fernando Echavarría; Leonardo Rocha; Ricardo Palacios; Oscar Ramírez; Juan D Vélez; Judith E Epstein; Thomas L Richie; Myriam Arévalo-Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

2.  Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival.

Authors:  Aminatou Kone; Marga van de Vegte-Bolmer; Rianne Siebelink-Stoter; Geert-Jan van Gemert; Antoine Dara; Hamidou Niangaly; Adrian Luty; Ogobara K Doumbo; Robert Sauerwein; Abdoulaye A Djimde
Journal:  Int J Parasitol       Date:  2010-06-02       Impact factor: 3.981

3.  A quantitative risk assessment approach for mosquito-borne diseases: malaria re-emergence in southern France.

Authors:  Nicolas Ponçon; Annelise Tran; Céline Toty; Adrian Jf Luty; Didier Fontenille
Journal:  Malar J       Date:  2008-08-01       Impact factor: 2.979

4.  Use of Plasmodium falciparum culture-adapted field isolates for in vitro exflagellation-blocking assay.

Authors:  Louis-Jérôme Leba; Lise Musset; Stéphane Pelleau; Yannick Estevez; Caroline Birer; Sébastien Briolant; Benoit Witkowski; Didier Ménard; Michael J Delves; Eric Legrand; Christophe Duplais; Jean Popovici
Journal:  Malar J       Date:  2015-06-04       Impact factor: 2.979

5.  Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection.

Authors:  Anthony Siau; Olivier Silvie; Jean-François Franetich; Samir Yalaoui; Carine Marinach; Laurent Hannoun; Geert-Jaan van Gemert; Adrian J F Luty; Emmanuel Bischoff; Peter H David; Georges Snounou; Catherine Vaquero; Patrick Froissard; Dominique Mazier
Journal:  PLoS Pathog       Date:  2008-08-08       Impact factor: 6.823

6.  KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.

Authors:  Kelli L Kuhen; Arnab K Chatterjee; Matthias Rottmann; Kerstin Gagaring; Rachel Borboa; Jennifer Buenviaje; Zhong Chen; Carolyn Francek; Tao Wu; Advait Nagle; S Whitney Barnes; David Plouffe; Marcus C S Lee; David A Fidock; Wouter Graumans; Marga van de Vegte-Bolmer; Geert J van Gemert; Grennady Wirjanata; Boni Sebayang; Jutta Marfurt; Bruce Russell; Rossarin Suwanarusk; Ric N Price; Francois Nosten; Anchalee Tungtaeng; Montip Gettayacamin; Jetsumon Sattabongkot; Jennifer Taylor; John R Walker; David Tully; Kailash P Patra; Erika L Flannery; Joseph M Vinetz; Laurent Renia; Robert W Sauerwein; Elizabeth A Winzeler; Richard J Glynne; Thierry T Diagana
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.